An exosome-based liquid biopsy to predict molecular residual disease for the identification of high-risk patients with stage II-III colorectal cancer: the CLEAR study.
- DOI
- 10.1186/s12943-026-02624-7
- Published
- 2026 Mar 3
- Container
- Molecular cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12943-026-02624-7,
title = {An exosome-based liquid biopsy to predict molecular residual disease for the identification of high-risk patients with stage II-III colorectal cancer: the CLEAR study.},
author = {Miyazaki K and Montcusí B and Morine Y and Okuno K and Pascual M and Tokunaga T and Noma T and Kinugasa Y and Shimada M and Cai G and Pera M and Goel A},
year = {2026},
journal = {Molecular cancer},
doi = {10.1186/s12943-026-02624-7},
url = {https://doi.org/10.1186/s12943-026-02624-7}
}RIS
TY - JOUR TI - An exosome-based liquid biopsy to predict molecular residual disease for the identification of high-risk patients with stage II-III colorectal cancer: the CLEAR study. AU - Miyazaki K AU - Montcusí B AU - Morine Y AU - Okuno K AU - Pascual M AU - Tokunaga T AU - Noma T AU - Kinugasa Y AU - Shimada M AU - Cai G AU - Pera M AU - Goel A PY - 2026 JO - Molecular cancer DO - 10.1186/s12943-026-02624-7 UR - https://doi.org/10.1186/s12943-026-02624-7 ER -
APA
K, M., B, M., Y, M., K, O., M, P., T, T., T, N., Y, K., M, S., G, C., M, P., & A, G. (2026). An exosome-based liquid biopsy to predict molecular residual disease for the identification of high-risk patients with stage II-III colorectal cancer: the CLEAR study.. Molecular cancer. https://doi.org/10.1186/s12943-026-02624-7
Source records
- pubmed · retrieved 2026-11-10T13:11:33.155Z